Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study
Introduction Bladder cancer is common in the elderly, with smoking as a major risk factor. This study assesses the global burden of bladder cancer attributable to smoking, using data from 204 countries and regions (1990–2021). Methods Mortality, age-standardized mortality rates (ASMR), disability-a...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Publishing
2025-06-01
|
Series: | Tobacco Induced Diseases |
Subjects: | |
Online Access: | https://www.tobaccoinduceddiseases.org/Smoking-related-bladder-cancer-burden-from-1990-to-2021-An-age-period-cohort-analysis,204744,0,2.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Introduction
Bladder cancer is common in the elderly, with smoking as a major
risk factor. This study assesses the global burden of bladder cancer attributable
to smoking, using data from 204 countries and regions (1990–2021).
Methods
Mortality, age-standardized mortality rates (ASMR), disability-adjusted life
years (DALYs), and age-standardized DALY rates (ASDR) were extracted from
the Global Burden of Disease (GBD) 2021 study. The burden of smoking-related
bladder cancer was analyzed by age, gender, and sociodemographic index (SDI).
Results
Between 1990 and 2021, global deaths due to smoking-related bladder
cancer increased by 42.9%, while disability rose by 31.0%. In 2021, the global
number of bladder cancer deaths due to smoking reached 58766 (95% UI: 49381–
70891). Despite these increases, both ASMR and ASDR declined globally. Males
experienced a higher increase in mortality and disability, with rates approximately
10 times higher than females. Middle SDI countries saw the largest rise in burden.
The annual decline in mortality was 2.06%, greater in males than females.
Conclusions
The burden of smoking-related bladder cancer is higher in males,
middle-aged and elderly individuals, and medium to high SDI countries. Targeted
prevention and health policies are crucial to reducing the disease’s impact on
populations and healthcare systems. |
---|---|
ISSN: | 1617-9625 |